covid19.figshare.com
      updated 7 april 2020 at 01:08 GMT
Submit or suggest more data

Treatments studied

Findings listed here should only be used for research purposes. No individual should interpret these findings for any self-diagnosis or self-medication without the prior approval from competent international health/medical regulatory agencies.

Substances / Treatments
Proportion

Remdesivir

Darunavir

Chloroquine

Lopinavir

Interferon

74.9%

70.6%

1.1%

8.2%

-

Breakdown from sources

CMK

AG7088 (rupintrivir)

Lopinavir

Rapid Identification of Potential Inhibitors of SARS-CoV-2 Main Protease by Deep Docking of 1.3 Billion Compounds

Anh-Tien Ton Francesco Gentile Michael Hsing Fuqiang Ban Artem Cherkasov

dataset
 listed on 
29.3.2020

Other related sources

Respiratory disease and virus shedding in rhesus macaques inoculated with SARS-CoV-2
Vincent J. Munster Friederike Feldmann Brandi Williamson Neeltje van Doremalen Lizzette Perez-Perez Jonathan Schulz Kimberly Meade-White Atsushi Okumura Julie Callison Beniah Brumbaugh Victoria Avanzato Rebecca Rosenke Patrick Hanley Dana Scott Elizabeth Fischer Emmie de Wit
listed on:
April 14, 2020
Corona Virus Disease (COVID-19) Outbreak and the Strategy for Prevention
Ahmad Naeem Sajed, Kapil Amgain
listed on:
April 6, 2020
G6PD+SARS-CoV-2 Pathogenesis
Yuliya Buinitskaya, Roman Gurinovich
listed on:
April 6, 2020
COVID-19: Teaching Points From the South Korean Experience
Elizabeth A David Young Tae Kim Samina Park Sang-Min Lee Hogeol Ryu Anthony W Kim
listed on:
April 6, 2020
COVID-19 vaccine candidates: Prediction and validation of 174 novel SARS-CoV-2 epitopes
Marek Prachar Sune Justesen Daniel Bisgaard Steen-Jensen Stephan Thorgrimsen Erik Jurgons Ole Winther Frederik Otzen Bagger
listed on:
April 6, 2020
Computational Prediction of Mutational Effects on the SARS-CoV-2 Binding by Relative Free Energy Calculations
Junjie Zou Jian Yin Lei Fang Mingjun Yang Tianyuan Wang Weikun Wu Peiyu Zhang
listed on:
March 30, 2020
Data supporting figures, tables and supplementary information in the published article: Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
Xiuyuan Ou Yan Liu Xiaobo Lei Pei Li Dan Mi Lili Ren Li Guo Ruixuan Guo Ting Chen Jiaxin Hu Zichun Xiang Zhixia Mu Xing Chen Jieyong Chen Keping Hu Qi Jin Jianwei Wang Zhaohui Qian
listed on:
March 30, 2020